Catamaran Bio Launches with $42 Million Financing to Develop Off‑the‑Shelf CAR-NK Cell Therapies to Treat Solid Tumors

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2KApDIN
via IFTTT